Mauna Kea Technologies
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Mauna Kea Technologies sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Mauna Kea Technologies: 6 sponsored US clinical trials, none currently recruiting.
Mauna Kea Technologies sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Pancreatic Cancer, with 2 trials.
Upper-quartile sponsor footprint
Mauna Kea Technologies sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
NCT01770405
Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
NCT01793246
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
NCT01392274
CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
NCT01032044
A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
NCT00779688
Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy
NCT00795184
Therapeutic Areas
How the Mauna Kea Technologies archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Pancreatic Cancer (2 trials), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Mauna Kea Technologies: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Mauna Kea Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Mauna Kea Technologies page
6 registered trials is a research-attention snapshot, not an endorsement of Mauna Kea Technologies or any single study.
- None of Mauna Kea Technologies's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pancreatic Cancer is the condition Mauna Kea Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pancreatic Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mauna Kea Technologies pipeline card: 6 registered trials from official public datasets.Report a data error.